for the Period Ended 31 March 2025
| Profit and loss | |
| Balance sheet | |
| Additional notes | |
| Balance sheet notes | |
| Community Interest Report |
for the Period Ended
| 2025 | 2024 | |
|---|---|---|
|
|
£ |
£ |
| Turnover: |
|
|
| Cost of sales: |
(
|
|
| Gross profit(or loss): |
|
|
| Administrative expenses: |
(
|
(
|
| Other operating income: |
|
|
| Operating profit(or loss): |
|
( |
| Profit(or loss) before tax: |
|
( |
| Tax: |
(
|
|
| Profit(or loss) for the financial year: |
|
( |
As at
| Notes | 2025 | 2024 | |
|---|---|---|---|
|
|
£ |
£ |
|
| Current assets | |||
| Cash at bank and in hand: |
|
|
|
| Total current assets: |
|
|
|
| Creditors: amounts falling due within one year: | 3 |
(
|
(
|
| Net current assets (liabilities): |
|
( |
|
| Total assets less current liabilities: |
|
( |
|
| Total net assets (liabilities): |
|
( |
|
| Members' funds | |||
| Profit and loss account: |
|
( |
|
| Total members' funds: |
|
( |
The notes form part of these financial statements
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 31 March 2025
Basis of measurement and preparation
Turnover policy
for the Period Ended 31 March 2025
| 2025 | 2024 | |
|---|---|---|
| Average number of employees during the period |
|
|
for the Period Ended 31 March 2025
| 2025 | 2024 | |
|---|---|---|
| £ | £ | |
| Other creditors |
|
|
| Total |
|
|
Cells of a Generation C.I.C. works to address health inequalities related to sickle cell disorder, with a particular focus on increasing awareness and encouraging blood donation among Black and ethnically diverse communities. During the year ended 31 March 2025, the company delivered a programme of community engagement, education, and creative health advocacy designed to make information about sickle cell disorder accessible, culturally relevant, and engaging. Key activities during the year included: The development and delivery of The Crisis Saga, a comic book series used as an educational tool to engage young people and community audiences in conversations about sickle cell disorder and blood donation. The production of The Lifeline Conversations, a short documentary exploring lived experiences of sickle cell disorder and the motivations behind blood donation, using personal storytelling to encourage behavioural change. Delivery of workshops and outreach sessions, including virtual workshops and in-person sessions at Enfield College and Tottenham College, using visual storytelling to support health education. Community and cultural outreach at venues including Kindred (Hammersmith) and Recess Land (Margate), engaging audiences in informal and accessible settings. Through these activities, the company contributed to increased awareness of sickle cell disorder and the importance of blood donation, particularly among first-time donors. Feedback from workshops, screenings, and outreach events indicated that creative and interactive formats were effective in encouraging dialogue, addressing misconceptions, and reducing barriers to donation. The company’s work supported NHS Blood and Transplant’s wider efforts to increase donor engagement and helped foster greater understanding of the need for ethnically matched blood donations for people living with sickle cell disorder. Looking ahead, the company intends to build on this work by developing The Lifeline Conversations into a recurring engagement format, expanding digital engagement through its website and media platforms, continuing partnership work with NHS Blood and Transplant, and strengthening relationships with educational institutions and creative collaborators to sustain long-term community impact.
The company’s stakeholders during the year included: 1. Individuals living with sickle cell disorder and their families 2. NHS Blood and Transplant (NHSBT) 3. Artists, educators, and community partners 4. The directors of the company The directors were actively involved in shaping and reviewing the company’s activities and community engagement approach throughout the year. Regular discussions between directors informed strategic decisions, programme design, and priorities for outreach and partnerships, ensuring that the company’s activities aligned with its community interest purpose. The company maintained ongoing engagement with NHS Blood and Transplant through quarterly discussions. These consultations informed the timing, focus, and messaging of outreach activities, particularly in response to periods of reduced blood supply. Engagement with individuals with lived experience of sickle cell disorder, alongside feedback gathered during workshops, screenings, and outreach events, helped ensure that activities remained accurate, respectful, and community-led. Feedback was used to refine creative formats, improve accessibility, and strengthen messaging around blood donation.
The total amount paid or receivable by directors in respect of qualifying services was £1210 There were no other transactions or arrangements in connection with the remuneration of directors, or compensation for director’s loss of office, which require to be disclosed
No transfer of assets other than for full consideration
This report was approved by the board of directors on
29 December 2025
And signed on behalf of the board by:
Name: Sharon Browne-Peter
Status: Director